1. Home
  2. AVDL vs CLDX Comparison

AVDL vs CLDX Comparison

Compare AVDL & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • CLDX
  • Stock Information
  • Founded
  • AVDL 2015
  • CLDX N/A
  • Country
  • AVDL Ireland
  • CLDX United States
  • Employees
  • AVDL N/A
  • CLDX N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • AVDL Health Care
  • CLDX Health Care
  • Exchange
  • AVDL Nasdaq
  • CLDX Nasdaq
  • Market Cap
  • AVDL 1.4B
  • CLDX 1.6B
  • IPO Year
  • AVDL 1996
  • CLDX 2008
  • Fundamental
  • Price
  • AVDL $15.66
  • CLDX $24.46
  • Analyst Decision
  • AVDL Strong Buy
  • CLDX Strong Buy
  • Analyst Count
  • AVDL 8
  • CLDX 9
  • Target Price
  • AVDL $20.88
  • CLDX $46.13
  • AVG Volume (30 Days)
  • AVDL 1.5M
  • CLDX 1.5M
  • Earning Date
  • AVDL 11-11-2025
  • CLDX 11-05-2025
  • Dividend Yield
  • AVDL N/A
  • CLDX N/A
  • EPS Growth
  • AVDL N/A
  • CLDX N/A
  • EPS
  • AVDL N/A
  • CLDX N/A
  • Revenue
  • AVDL $221,075,000.00
  • CLDX $5,790,000.00
  • Revenue This Year
  • AVDL $64.56
  • CLDX N/A
  • Revenue Next Year
  • AVDL $30.60
  • CLDX N/A
  • P/E Ratio
  • AVDL N/A
  • CLDX N/A
  • Revenue Growth
  • AVDL 132.35
  • CLDX N/A
  • 52 Week Low
  • AVDL $6.38
  • CLDX $14.40
  • 52 Week High
  • AVDL $16.66
  • CLDX $47.00
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 65.57
  • CLDX 57.09
  • Support Level
  • AVDL $14.78
  • CLDX $24.02
  • Resistance Level
  • AVDL $16.04
  • CLDX $25.51
  • Average True Range (ATR)
  • AVDL 0.57
  • CLDX 1.16
  • MACD
  • AVDL -0.11
  • CLDX 0.14
  • Stochastic Oscillator
  • AVDL 79.23
  • CLDX 66.11

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: